Grygiel Nancy A.'s Form 4 filing
Amgen IncAMGN · filed Dec 4, 2023
- Accession no.
- 0001127602-23-028779
- Filed
- Dec 4, 2023
- Trade date
- Dec 4, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $572.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grygiel Nancy A.CIK 0001816414 | Officer (SVP & CCO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | Common Stock | SSaleDisposed | −2,096 | $273.03F1 | −$572,270.88 | 10,874 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is an average price. The prices ranged from $273.00 to $273.17 per share. Full information regarding the number of shares purchased at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
Referenced by the price of 1 transaction in Table I.